10-K/A: Cardiff Lexington Corporation Files Amended 10-K After SEC Comments, Reports Improved Financials

Cardiff Lexington Corporation files an amendment to its 2023 annual report to address SEC comments, highlighting a shift to profitability and growth in its healthcare segment.

Summary

• Cardiff Lexington Corporation filed an amended 10-K report to address comments from the SEC.
• The company is an acquisition holding company focused on healthcare, aiming for 80% established profitable companies and 20% second-stage startups.
• The company's healthcare business, Nova, saw a revenue increase of 10.85% to $11,853,266 in 2023, while cost of sales decreased by 12.30% to $3,560,624.
• Gross profit increased by 25.02% to $8,292,642, with a gross margin of 69.96% in 2023.
• The company reported a net income of $3,028,394 for 2023, a significant turnaround from a net loss of $5,429,521 in 2022.
• The company's typical accounts receivable collection lifecycle is between eighteen and twenty-four months, which creates liquidity and cash flow risks.
• The company sold its financial services business, Platinum Tax Defenders, in 2023.
• The company's real estate business, Edge View, has not generated any revenues to date, except for the sale of three parcels of land in 2021.

Sentiment

Score: 7

Explanation: The document shows a positive shift in financial performance with a return to profitability, but there are still significant risks and challenges related to the company's business model and internal controls. The company's reliance on external financing and the extended accounts receivable cycle are also concerns.

Positives

• The company's healthcare segment is experiencing growth and improved profitability.
• The company has successfully turned around from a net loss in 2022 to a net income in 2023.
• The company's gross margin has improved significantly.
• The company is focused on acquiring established, profitable healthcare companies.

Negatives

• The company's extended accounts receivable collection cycle poses liquidity and cash flow risks.
• The company has identified material weaknesses in its internal control over financial reporting.
• The company's real estate business has not generated significant revenue.
• The company relies on external financing for acquisitions and operations.

Risks

• The company's ability to continue as a going concern is dependent on raising additional capital.
• The company's extended accounts receivable collection cycle creates liquidity and cash flow constraints.
• The company may face challenges in integrating acquired businesses.
• The company faces competition for acquisitions and may have to pay sub-optimal prices.
• The company's healthcare business is subject to extensive regulations and compliance risks.
• The company's real estate business is subject to demand fluctuations and environmental liabilities.
• The company's common stock is subject to significant price volatility and may be difficult to trade.

Future Outlook

The company intends to continue its acquisition strategy, focusing on healthcare companies and related financial services, with a goal of 80% established profitable companies and 20% second-stage startups. The company also plans to develop its real estate holdings.

Management Comments

• Management believes that current working capital and current and expected additional financing should be sufficient to fund operations and satisfy obligations for at least one year.
• Management estimates that the ten healthcare facilities are operating at 35% capacity as of December 31, 2023.
• Management plans to enter into a joint venture agreement with a developer for the real estate development in Salmon, Idaho.

Industry Context

The healthcare industry is highly competitive, with increasing pressure on cost containment and reimbursement rates. The company's focus on plaintiff-related care and bodily injury policies partially insulates it from declining Medicare/Medicaid reimbursements. The company also faces competition from other healthcare providers, including hospitals and outpatient facilities.

Comparison to Industry Standards

• The company's gross margin of 69.96% is relatively high compared to some healthcare providers, but this is likely due to its focus on a specific niche market.
• The company's extended accounts receivable collection cycle is unusual compared to most businesses, which typically collect receivables within 30-90 days.
• The company's reliance on external financing is common among smaller, growing companies, but the level of dependence may be a concern.
• The company's lack of independent directors and material weaknesses in internal controls are not in line with best practices for public companies.

Management Changes

Corporate Governance

Legal Proceedings

• The company is involved in a breach of contract lawsuit with Absolute Medical Group, LLC, with a counterclaim filed by the company.
• The company filed a complaint against Mark Adams in Idaho, alleging breach of contract, breach of fiduciary duties, and conversion, with a counterclaim filed by the defendant.

Related Party Transactions

• The company has short-term advances from the Chairman of the Board that are non-interest bearing and due on demand.
• The company has amounts due to previous owners of Edge View who are current managers, which are due on demand and do not bear interest.

Stakeholder Impact

• Shareholders may benefit from the company's improved financial performance, but face risks due to the company's business model and internal control issues.
• Employees may benefit from the company's growth and potential for future success, but may also face uncertainty due to the company's financial challenges.
• Customers of the healthcare business may benefit from the company's services, but may also be affected by the company's financial stability.
• Creditors may face risks due to the company's reliance on external financing and its extended accounts receivable collection cycle.

Next Steps

• The company plans to continue its acquisition strategy in the healthcare sector.
• The company plans to develop its real estate holdings through a joint venture.
• The company is working to improve its internal controls and address material weaknesses.
• The company is seeking additional financing to support its operations and acquisitions.

Key Dates

Keywords

healthcare, acquisitions, financial performance, accounts receivable, internal control, real estate, profitability, medical services, debt financing, equity financing